Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cocrystal Pharma Stock (NASDAQ: COCP) stock price, news, charts, stock research, profile.
Day Range2.751 - 2.900 | 52 Wk Range1.740 - 7.559 | Open / Close2.800 / - | Float / Outstanding7.757M / 8.143M |
Vol / Avg.30.801K / 53.338K | Mkt Cap22.963M | P/E- | 50d Avg. Price2.440 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float7.757M | EPS-4.710 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-22 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.480 | -0.700 | -0.2200 | ||||
REV | 80.000K | 0 | -80.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cocrystal Pharma (NASDAQ: COCP) through any online brokerage.
Other companies in Cocrystal Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Iterum Therapeutics (NASDAQ:ITRM), Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Universe Pharmaceuticals (NASDAQ:UPC).
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on Tuesday, January 24, 2023. The analyst firm set a price target for 35.00 expecting COCP to rise to within 12 months (a possible 1141.13% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cocrystal Pharma (NASDAQ: COCP) is $2.82 last updated Today at February 1, 2023 at 4:40 PM UTC.
There are no upcoming dividends for Cocrystal Pharma.
Cocrystal Pharma’s Q4 earnings are confirmed for Wednesday, March 22, 2023.
There is no upcoming split for Cocrystal Pharma.
Cocrystal Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.